Product Launch Allergan (Forest Labs) actively expands its portfolio with new cosmetic and aesthetic offerings such as Latisse, presenting ongoing opportunity for cross-sell and dermatology-focused partnerships and advertising collaborations.

Facility Expansion Recent facility expansions in Kansas City indicate capacity growth and potential for regional supply chain partnerships, contract manufacturing opportunities, and enhanced distribution capabilities across North America.

Aesthetics Focus Strong emphasis on aesthetics and eye care products, including JUVÉDERM VOLUX and TissuGlu, suggests sales potential in injectable and surgical adhesion markets, with avenues for clinical collaboration and education programs.

Strategic Acquisition AbbVie’s acquisition of Allergan in 2020 points to integrated corporate capabilities and potential for multi-product collaboration, licensing deals, and leverage of AbbVie’s broader pharma channels.

Financial Scale Revenue in the multi-billion range and a sizeable employee base create opportunities for large-scale enterprise partnerships, channel partner programs, and co-marketing arrangements with high-reach distributors.